Are you looking for expert advice...

How we are supported


Support from organisations including licensed producers, sector leaders and individuals allows the Medical Cannabis Clinicians Society to reach our goals.

This unrestricted educational grant funding allows the Society to provide CPD-accredited training, events and peer support to develop and increase the knowledge and skills of the biggest and most respected network of prescribers in the UK.

Organisations wishing to support the Society are invited to contact us to learn more about the benefits of working together.

Our Supporters
Script Assist

Script Assist


Script Assist (formerly Sana Healthcare) is a free-to-use governance tool and dedicated patient app combined with a data-led formulary, enabling medical cannabis prescribing by independent doctors working from any private setting.

Supporting the Society since January 2023, Script Assist provides doctors with optional Multidisciplinary Team reviews, products specific to indication areas with published findings, dosing guidance, real-time stock availability and patient outcome tracking through its dedicated patient app.

View Website

Stenocare

Stenocare


STENOCARE, founded in 2017, is a Danish company that cultivates, produces, imports and sells prescription-based medical cannabis. In 2018, STENOCARE became the first Danish company to obtain all permits to cultivate, import and trade in medicinal cannabis oils in the Danish pilot program. STENOCARE is the only Danish company that has succeeded in having medical oil-based cannabis products approved for the Danish pilot program and supplies pharmaceutically-produced and uniform oil products to patients in Denmark, Sweden, Norway, UK and Australia.

View Website

Khiron Med

KhironMed


KhironMed is the medical division of KHIRON Life Sciences Corporation, a leading, vertically integrated, international medical cannabis company with core operations in Latin America and Europe. It founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.

View Website

Ananda Developments


Ananda’s mission is to become a leading UK grower and provider of high quality, consistent carbon zero medical cannabis for the UK and international markets.

Ananda Developments holds 100% of Tiamat Agriculture Limited, which owns 50% of DJT Group Limited which has been granted a Home Office licence to grow >0.2% THC cannabis in the United Kingdom.

View Website

Other supporters


Individuals wishing to support the work of The Medical Cannabis Clinicians Society are encouraged to attend our public events, conferences and roadshows. Sign up to our mailing list to be the first to know about our activities and contact us to discuss your support.

Learn more about the benefits of becoming a memberJoin the MCCS

News

News, case studies, clinician profiles and patient stories from the Medical Cannabis Clinicians Society.

Patient stories

Patient stories

Hear from patients benefiting from medical cannabis treatments in the UK.

Join the MCCS

Join the MCCS

Key reasons to join MCCS, a supportive community growing by the day. Exclusive prescribing information, product details and peer support.

The Primary Care Cannabis Network becomes part of  the Medical Cannabis Clinicians Society 
March 17, 2023

The Primary Care Cannabis Network becomes part of  the Medical Cannabis Clinicians Society 

The Medical Cannabis Clinicians Society is pleased to announce that the Primary Care Cannabis Network (PCCN) has become a part of our Society. This is an important step forward in…

UK CBMP Product Formulary Update
February 20, 2023

UK CBMP Product Formulary Update

The Medical Cannabis Clinicians Society maintains a list of available cannabis-based medical products regularly updated and shared with its members. As a member of the Medical Cannabis Clinicians Society, clinicians…

Knowledge sharing at CT-Cann 2023
February 20, 2023

Knowledge sharing at CT-Cann 2023

The Medical Cannabis Clinicians Society recently endorsed and participated in the 2nd International Congress on Clinical Trials on Cannabis (CT-Cann2023), an education and scientific conference aimed at clinicians and researchers…

MCCS endorse 2nd International Congress on Clinical Trials on Cannabis
November 24, 2022

MCCS endorse 2nd International Congress on Clinical Trials on Cannabis

  The Medical Cannabis Clinicians Society is proud to officially endorse the 2nd International Congress on Clinical Trials on Cannabis, taking place on 15 & 16 February 2023 in London.…